PMID- 27468299
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160729
LR  - 20200930
IS  - 1710-1484 (Print)
IS  - 1710-1492 (Electronic)
IS  - 1710-1484 (Linking)
VI  - 12
DP  - 2016
TI  - Clinical Experience with Octagam(R) 10 %, a solvent detergent virus inactivated 
      intravenous immunoglobulin: a Canadian retrospective review of utilization.
PG  - 32
LID - 10.1186/s13223-016-0138-9 [doi]
LID - 32
AB  - In Canada, intravenous immune globulin (IVIg) products are licensed for six 
      disease indications, however it has been demonstrated that patients with a number 
      of other conditions also benefit from IVIg. Here we report the routine clinical 
      use of Octagam((R)) 10 % across three Canadian institutions. A total of 135 
      patients were treated with Octagam((R)), for conditions represented by five 
      distinct indication groups. The results of this review indicate that Octagam((R)) 
      has been well adopted and is prescribed to Canadian patients similar to other 
      IVIg products. In alignment with current practices, 85 % of Octagam's utilization 
      was classified as appropriate based on Canadian IVIg guidelines.
FAU - Betschel, Stephen D
AU  - Betschel SD
AUID- ORCID: 0000-0002-6631-4438
AD  - St Michael's Hospital and the University of Toronto, 30 Bond St, Toronto, ON M5B 
      1W8 Canada.
FAU - Warrington, Richard J
AU  - Warrington RJ
AD  - Head, Section of Allergy & Immunology, Department of Internal Medicine, 
      University of Manitoba, Winnipeg Health Science Center, GC319 820 Sherbrook St, 
      Winnipeg, MB R3A 1R9 Canada.
FAU - Schellenberg, Robert
AU  - Schellenberg R
AD  - St Paul's Hospital and the University of British Columbia, 1081 Burrard St, 
      Vancouver, BC V6C 1Y6 Canada.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20160727
PL  - England
TA  - Allergy Asthma Clin Immunol
JT  - Allergy, asthma, and clinical immunology : official journal of the Canadian 
      Society of Allergy and Clinical Immunology
JID - 101244313
PMC - PMC4962395
OTO - NOTNLM
OT  - IVIg
OT  - Indication
OT  - Octagam(R)
EDAT- 2016/07/29 06:00
MHDA- 2016/07/29 06:01
PMCR- 2016/07/27
CRDT- 2016/07/29 06:00
PHST- 2016/04/24 00:00 [received]
PHST- 2016/07/06 00:00 [accepted]
PHST- 2016/07/29 06:00 [entrez]
PHST- 2016/07/29 06:00 [pubmed]
PHST- 2016/07/29 06:01 [medline]
PHST- 2016/07/27 00:00 [pmc-release]
AID - 138 [pii]
AID - 10.1186/s13223-016-0138-9 [doi]
PST - epublish
SO  - Allergy Asthma Clin Immunol. 2016 Jul 27;12:32. doi: 10.1186/s13223-016-0138-9. 
      eCollection 2016.